n-dichlorofluoromethylthio-n',n'-dimethyl-n-p-tolylsulfamide has been researched along with Insulin Sensitivity in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baumgarner, BL; Brown, SL; Davis, AF; Shorter, KS; Thomas, AA | 1 |
Aldirawi, H; Dybala, MP; Hara, M; Haro, F; Kirkley, AG; Regnier, SM; Ruiz, D; Sargis, RM | 1 |
El-Hashani, E; Hayes, ET; Huang, L; Johnson, DN; Kamau, W; Kirkley, AG; Massad, NL; Neel, BA; Regnier, SM; Sargis, RM; Thomas, CC; Williams, AK; Ye, H; Zhang, C; Zhang, X | 1 |
Brady, MJ; Brock, CO; Carlton, DA; Hickey, AT; Lin, Y; Neel, BA; Sargis, RM | 1 |
4 other study(ies) available for n-dichlorofluoromethylthio-n',n'-dimethyl-n-p-tolylsulfamide and Insulin Sensitivity
Article | Year |
---|---|
Cellular fatty acid level regulates the effect of tolylfluanid on mitochondrial dysfunction and insulin sensitivity in C2C12 skeletal myotubes.
Topics: Animals; Cell Line; Endocrine Disruptors; Fatty Acids; Insulin; Insulin Resistance; Membrane Potential, Mitochondrial; Mice; Mitochondrial Diseases; Muscle Fibers, Skeletal; Muscle, Skeletal; Oleic Acid; Protein Synthesis Inhibitors; Sulfonamides; Toluidines | 2018 |
Developmental exposure to the endocrine disruptor tolylfluanid induces sex-specific later-life metabolic dysfunction.
Topics: Adiposity; Animals; Endocrine Disruptors; Female; Insulin Resistance; Maternal Exposure; Metabolic Diseases; Mice; Mice, Inbred C57BL; Pregnancy; Prenatal Exposure Delayed Effects; Receptors, Glucocorticoid; Sex Characteristics; Sulfonamides; Toluidines | 2019 |
Dietary exposure to the endocrine disruptor tolylfluanid promotes global metabolic dysfunction in male mice.
Topics: Adiponectin; Adiposity; Animals; Circadian Rhythm; Eating; Endocrine Disruptors; Energy Metabolism; Gene Expression Regulation; Glucose Tolerance Test; Insulin; Insulin Resistance; Leptin; Male; Metabolic Diseases; Mice; Oligonucleotide Array Sequence Analysis; RNA; Sulfonamides; Toluidines; Weight Gain | 2015 |
The novel endocrine disruptor tolylfluanid impairs insulin signaling in primary rodent and human adipocytes through a reduction in insulin receptor substrate-1 levels.
Topics: Adipocytes; Aniline Compounds; Animals; Cells, Cultured; Endocrine Disruptors; Humans; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Leptin; Male; Mice; Mice, Inbred C57BL; Phosphatidylinositol 3-Kinase; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptor, Insulin; RNA, Messenger; Signal Transduction; Sulfonamides; Toluidines | 2012 |